Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-05-22
1996-03-26
Ivy, C. Warren
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
549299, C07D30783
Patent
active
055022162
ABSTRACT:
An anti-hyperlipemic agent which has a potent activity of reducing LDL and VLDL cholesterols, which are thought to be a risk factor for arteriosclerosis among total blood cholesterols, and which is excellent in the antioxidant activity on LDL, is provided. Additionally, a compound and a pharmaceutically acceptable salt thereof are disclosed, which is represented by Formula (I): ##STR1## wherein R.sup.1 is a lower alkyl, cycloalkyl, cycloalkyl-lower alkyl, aryl or aralkyl group which is optionally substituted; R.sup.2 is a group represented by the formula: -COOR' (wherein R' is a lower alkyl or aralkyl which is optionally substituted), lower alkyl or halogenated lower alkyl; or R.sup.1 and R.sup.2, together with adjacent carbonyl group, form a cyclohexanone ring represented by the formula: ##STR2## R.sup.3 is a phenyl group optionally being substituted, and, ring A is a benzene nucleus which is optionally substituted, or a heterocyclic ring containing S or 0 optionally being substituted!.
REFERENCES:
patent: 4771072 (1988-09-01), Iwasaki et al.
patent: 4840951 (1989-06-01), Iwasaki et al.
Broom et al., "A General Route to Substituted Naphthols", J. C. S. Chem. Comm., 1978, pp. 162-164.
Ichihashi Teruhisa
Kida Shiro
Mizui Takuji
Mori Sachio
Takechi Shozo
Ivy C. Warren
Owens Amelia
Shionogi & Co. Ltd.
LandOfFree
Lignan analogues, methods of preparation thereof and anti-hyperl does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lignan analogues, methods of preparation thereof and anti-hyperl, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lignan analogues, methods of preparation thereof and anti-hyperl will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-917039